Hutch News

Results per Page: 20
  • 5
  • 10
  • 20
  • 50
  • 100
Osteoporosis drug may reduce breast cancer risk

Osteoporosis drug may reduce breast cancer risk

Andrea LaCroix and colleagues tie lasofoxifene to 79 percent lowered overall risk of breast cancer in postmenopausal women
Hutch News - November 08, 2010
Video: Beneficial breast cancer drug has its risks

Video: Beneficial breast cancer drug has its risks

Li study confirms his earlier finding that associates long-term tamoxifen use with more than four-fold increased risk of aggressive, difficult to treat type of contralateral breast cancer
Hutch News - August 26, 2009
A Call to Action — Women Across the State Needed for Breast Cancer Study Looking at Preventive Benefits of Tamoxifen and Raloxifene

A Call to Action — Women Across the State Needed for Breast Cancer Study Looking at Preventive Benefits of Tamoxifen and Raloxifene

Fred Hutchinson Cancer Research Center and its five satellite sites hope to recruit 200 women to the study over the next three years
News Releases - October 25, 2001
Major Breast Cancer Prevention Trial Seeks Minority Women During

Major Breast Cancer Prevention Trial Seeks Minority Women During

National Minority Cancer Awareness Week Five Sites in Washington and Oregon Hope to Recruit More Women To the Study of Tamoxifen and Raloxifene, known as STAR
News Releases - April 18, 2000
Last Modified, April 02, 2020